Melanoma News and Research

Latest Melanoma News and Research

Stress protein in fibroblasts appears to be an attractive cancer drug target

Stress protein in fibroblasts appears to be an attractive cancer drug target

Research reveals why many cancers are vulnerable to FDA-approved IDH1 inhibitors

Research reveals why many cancers are vulnerable to FDA-approved IDH1 inhibitors

Inhaled recombinant IL-15 tested in pet dogs with metastatic lung disease from osteosarcoma or melanoma

Inhaled recombinant IL-15 tested in pet dogs with metastatic lung disease from osteosarcoma or melanoma

Researchers demonstrate the double advantage of killer T-cells used in cancer immunotherapy

Researchers demonstrate the double advantage of killer T-cells used in cancer immunotherapy

Eating higher levels of fish may be linked to greater risk of malignant melanoma

Eating higher levels of fish may be linked to greater risk of malignant melanoma

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Scientists provide crucial insights into the roles of inflammation and oxidative stress in certain cancers

Scientists provide crucial insights into the roles of inflammation and oxidative stress in certain cancers

Researchers evaluate how hundreds of different mutations impact key function of breast cancer gene

Researchers evaluate how hundreds of different mutations impact key function of breast cancer gene

Counting metastatic lymph nodes is better for determining prognoses of solid tumors

Counting metastatic lymph nodes is better for determining prognoses of solid tumors

New "masked" version of immunotherapy could help fight cancer without causing side effects

New "masked" version of immunotherapy could help fight cancer without causing side effects

Study finds a link between aging and cancer metastases

Study finds a link between aging and cancer metastases

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

Study shows the SARS-CoV-2 accessory protein ORF7a inhibits HLA-I surface expression levels in human cells

UCLA researchers identify a method to make tumors susceptible to immune attack

UCLA researchers identify a method to make tumors susceptible to immune attack

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

Study: Cardiovascular mortality risk differs among cancer survivors by race/ethnicity and cancer types

New discovery could pave the way for more effective cancer immunotherapy

New discovery could pave the way for more effective cancer immunotherapy

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Novel mechanism to turn on cancer-killing T cells identified

Novel mechanism to turn on cancer-killing T cells identified

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

Immunogenicity of BNT162b2 COVID-19 vaccine in melanoma patients receiving immunotherapy

Deep visual proteomics is redefining cancer diagnostics

Deep visual proteomics is redefining cancer diagnostics

Researchers discover potential treatment approach for advanced uveal melanoma

Researchers discover potential treatment approach for advanced uveal melanoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.